✦ LIBER ✦

Increased serum levels of basic fibroblast growth factor in lung cancer patients: relevance to response of therapy and prognosis

✍ Scribed by Ueno, Kiyonobu; Inoue, Yoshikazu; Kawaguchi, Tomoya; Hosoe, Shigeto; Kawahara, Masaaki

Book ID: 118569480
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 88 KB
Volume: 31
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)00187-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased serum levels of basic fibrobla

Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma

✍ Kiyohide Fujimoto; Yuzo Ichimori; Tadao Kakizoe; Eigoro Okajima; Hiromi Sakamoto 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Increasing serum levels of basic fibrobl

Increasing serum levels of basic fibroblast growth factor in non small cell lung cancer indicates progressive disease

✍ Brattström, D; Bergqvist, M; Hesselius, P; Larsson, A; Wagenius, G; Brodin, O 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Serum levels of vascular endothelial gro

Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma

✍ Ullrich Graeven; Niko Andre; Eike Achilles; Carsten Zornig; Wolff Schmiegel 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 103 KB

Early increase in serum levels of the an

Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression

✍ P. Kurschat; S. Eming; D. Nashan; T. Krieg; C. Mauch 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

496 - Serum levels of vascular endotheli

496 - Serum levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients (pts) with soft tissue sarcoma (STS)

✍ U. Graeven; E.G. Achilles; M. Peiper; C. Knabbe; C. Zornig; W.H. Schmiege 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Serum levels of angiogenin, basic fibrob

Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia

✍ Nils Glenjen; Knut Anders Mosevoll; Øystein Bruserud 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 204 KB

Angiogenesis seems to be important both in the pathogenesis of acute myelogenous leukemia (AML) and for the susceptibility of AML blasts to chemotherapy. Recent clinical studies even suggest that antiangiogenic therapy can induce disease control in patients with AML relapse. In this context we have